WallStreetZenWallStreetZen

NASDAQ: NDRA
Endra Life Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their NDRA stock forecasts and price targets.

Forecast return on equity

Is NDRA forecast to generate an efficient return?

Company
-125.03%
Industry
-3.56%
Market
66.7%
NDRA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NDRA forecast to generate an efficient return on assets?

Company
-98.55%
Industry
9.2%
NDRA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NDRA earnings per share forecast

What is NDRA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$15.38

NDRA revenue forecast

What is NDRA's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$10.0k

NDRA vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
NDRA$6.00N/AN/A
MYNZ$5.00N/AN/A
ISPC$2.64N/AN/A
MDXH$2.00$6.00+200.00%Strong Buy
TTOO$0.28$5.00+1,685.71%Hold
View Top Diagnostic & Research Stocks

Endra Life Sciences Stock Forecast FAQ

What is NDRA's earnings growth forecast for 2025-2025?

(NASDAQ: NDRA) Endra Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Endra Life Sciences's earnings in 2025 is -$8,818,479.

In 2025, NDRA is forecast to generate -$8,257,645 in earnings, with the lowest earnings forecast at -$8,257,645 and the highest earnings forecast at -$8,257,645.

If you're new to stock investing, here's how to buy Endra Life Sciences stock.

What is NDRA's revenue growth forecast for 2025-2025?

(NASDAQ: NDRA) Endra Life Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Endra Life Sciences's revenue in 2025 is $0.

In 2025, NDRA is forecast to generate $5,369 in revenue, with the lowest revenue forecast at $5,369 and the highest revenue forecast at $5,369.

What is NDRA's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: NDRA) forecast ROA is -98.55%, which is lower than the forecast US Diagnostics & Research industry average of 9.2%.

What is NDRA's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: NDRA) Endra Life Sciences's current Earnings Per Share (EPS) is -$692.04. In 2025, NDRA's EPS is forecast to hit -$15.38 (min: -$15.38, max: -$15.38).

What is NDRA's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: NDRA) forecast ROE is -125.03%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.